Home PTC Therapeutics Expands Access For Translarna (Ataluren)
 

Keywords :   


PTC Therapeutics Expands Access For Translarna (Ataluren)

2014-11-05 07:13:37| drugdiscoveryonline Home Page

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Translarna™ (ataluren) has been approved to be included in the list of drugs reimbursable by the Italian National Health System under Law 648/96

Tags: access expands therapeutics ptc

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
11.10How Chinas crackdown turned finance high-flyers into rats
11.10Why even at 20 you should care about pension changes
11.10Meet the team paid to break into top-secret bases
10.102025 CoatingsTech Conference: Call for Papers Abstracts Due October 15, 2024
10.10Post-Tropical Cyclone Milton Forecast Discussion Number 23
10.10Post-Tropical Cyclone Milton Wind Speed Probabilities Number 23
10.10Post-Tropical Cyclone Milton Forecast Advisory Number 23
10.10Post-Tropical Cyclone Milton Public Advisory Number 23
More »